Two IP Law Firm Principals, the Only U.S. Patent Law Experts Invited by Chinese Pharmaceutical Professionals to Address Conference in Hangzhou, China, Wednesday, August 9
Speakers from Everest IP Law Group will Discuss Pharmaceutical Patent
Strategies, Case Law;
One, an IP Attorney and Chemist, The Other, a Harvard Medical School
Fellow, Ph.D., MBA
NORTHBROOK, Ill., July 28 LAWFUEL – Press Release Service — The China Pharmaceutical
Association (CPA) and the American Association of Pharmaceutical Scientists
(AAPS), cosponsors of an annual conference in China, have invited two
principals of a U.S. intellectual property law firm to address
pharmaceutical professionals in Hangzhou, China.
The two from Northbrook-based, Everest Intellectual Property Law Group
(Everest IP) — Joseph A. Fuchs, co-founder and managing partner of Everest
IP, and Dr. Tin-Chuen Yeung, co-founder and managing director — will be
the only speakers from a U.S. law firm to address attendees at the
prestigious, limited-attendance conference. They will speak in the Radisson
Plaza Hotel Hangzhou on Wednesday, August 9.
Fuchs will review and analyze patent enforcement claims and outcomes
involving such popular drugs as Zoloft(R), Accupril(R) and Zyprexa(R) while
Dr. Yeung will cover patent filing strategies to extend pharmaceutical
product life cycles in the rapidly developing Chinese pharmaceutical
market.
Other speakers at the four-day event for industry, academic, research
and government professionals include executives and scientists from Pfizer
Inc., Abbott Laboratories, Novartis Pharmaceutical Corp. and the FDA.
Prior to opening Everest IP, Fuchs and Dr. Yeung practiced in the IP
Group of the 200-attorney, Chicago law firm of Bell, Boyd & Lloyd LLC. Each
is admitted to practice before the U.S. Patent and Trademark Office.
Fuchs, a former partner at Bell, Boyd & Lloyd who has practiced IP law
for the past 16 years, is a pioneer in patent mapping and mining
(investigation). Also a former chemist, he has presented at professional
meetings and is published in professional and business journals, including
AmericanVenturemagazine.com, which featured an IP due diligence article he
co- authored with Dr. Yeung.
Dr. Yeung, a former Harvard Medical School Research Fellow who was
awarded the Damon Runyon-Walter Winchell Cancer Foundation Fellowship,
earned a Ph.D. in Pharmacology and an MBA from Northwestern’s Kellogg
School of Management. He was Head of Strategic Development for Life
Sciences at Bell, Boyd & Lloyd and a senior-level executive at Baxter
International Inc., where he managed acquisitions and strategic alliances
as well as technology development and licensing.
Profiled in the “The Scientist” (11/7/05), Dr. Yeung is an Advisory
Board member of the International Trade Club of Chicago and Health
Discovery Corporation, a publicly-held, biotechnology company in Savannah,
GA.
Clients of Everest IP, one of the few multi-partner, IP law firms on
Chicago’s North Shore, include Cardinal Health Inc., UOP LLC, the
University of Illinois and Rosalind Franklin University of Medicine and
Science.
